AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Nolato B

Quarterly Report Jul 19, 2018

2950_ir_2018-07-19_0963e427-821a-4278-ae76-81a3dd707327.pdf

Quarterly Report

Open in Viewer

Opens in native device viewer

Nolato AB (publ) six-month interim report 2018

Very strong quarter for all business areas

Second quarter of 2018 in brief

  • ‒ Sales increased to SEK 2,302 million (1,675)
  • ‒ Operating profit (EBITA) was SEK 266 million (178)
  • ‒ EBITA margin of 11.6% (10.6)
  • ‒ Profit after tax increased to SEK 204 million (131)
  • ‒ Basic earnings per share were SEK 7.75 (4.98)
  • ‒ Cash flow after investments was SEK 352 million (28)
  • First six months of 2018 in brief
  • ‒ Sales increased to SEK 4,341 million (3,045)
  • ‒ Operating profit (EBITA) was SEK 530 million (324) incl. non-recurring items of SEK 20 million (0)
  • ‒ Basic earnings per share were SEK 15.59 (9.09)
  • ‒ Cash flow after investments was SEK 539 million (31)
  • ‒ Continued solid financial position
Group highlights
Q2 Q2 Q1 - Q2 Q1 - Q2 Rolling Full year
SEK million unless otherwise specified Note 2018 2017 2018* 2017 12 months* 2017
Net sales 1 2,302 1,675 4,341 3,045 8,016 6,720
1)
Operating profit (EBITDA)
325 232 647 431 1,196 980
2)
Operating profit (EBITA)
266 178 530 324 969 763
EBITA margin, % 11.6 10.6 12.2 10.6 12.1 11.4
3)
Operating profit (EBIT)
2 264 174 525 316 958 749
Profit after financial income and expense 2 257 170 513 308 936 731
Profit after tax 204 131 410 239 743 572
Basic earnings per share, SEK 3 7.75 4.98 15.59 9.09 28.23 21.74
Diluted earnings per share, SEK 3 7.70 4.98 15.52 9.09 28.16 21.74
4)
Basic adjusted earnings per share, SEK
3 7.83 5.09 15.74 9.31 28.58 22.16
4)
Diluted adjusted earnings per share, SEK
3 7.78 5.09 15.67 9.31 28.50 22.15
Cash flow after investm., excl. acquisitions and disposals 352 28 539 31 1,004 496
Net investm. affecting cash fl., excl. acquis. and disposals 120 75 229 139 367 277
Cash conversion, %5) 104 66
Return on capital employed, % 32.0 22.3 32.0 22.3 32.0 26.6
Return on shareholders' equity, % 34.9 22.9 34.9 22.9 34.9 29.4
Equity/assets ratio, % 43 40 43 40 43 45
Net financial assets (+) / liabilities (–) 62 – 639 62 – 639 62 – 153

* Including non-recurring items of SEK 20 million in Q1 2018 that had a positive impact on earnings.

1) Operating profit (EBITDA): Earnings before financial income and expense, taxes and depreciation/amortisation.

2) Operating profit (EBITA): Earnings before financial income and expense, taxes and amortisation of intangible assets arising from acquisitions.

3) Operating profit (EBIT): Earnings before financial income and expense and taxes.

4) Adjusted earnings per share: Profit after tax, excluding amortisation of intangible assets arising from acquisitions, divided by the average number of shares.

5) Cash conversion: Cash flow after investments, excl. acquisitions and disposals, divided by operating profit (EBIT). Cash flow and operating profit have been adjusted by non-recurring items, if any.

This document is a translation from Swedish. In the event of any difference between this version and the Swedish original, the latter shall prevail.

Second quarter 2018

  • Sales were SEK 2,302 million (1,675); adjusted for currency, sales grew by a very strong 34%
  • Robust growth and increased earnings across all business areas
  • Extremely high volumes for Integrated Solutions in new product areas, fuelled by launch volumes and inventory build-up
  • Operating profit (EBITA) rose to SEK 266 million (178)
  • EBITA margin increased to 11.6% (10.6)
  • Strong cash flow after investments of SEK 352 million (28)

Sales

Consolidated sales rose by 37% to SEK 2,302 million (1,675). Adjusted for currency, sales increased by a very strong 34%. Organic growth was strong for all business areas, but was exceptionally high for Integrated Solutions.

Medical Solutions sales increased to SEK 562 million (498); adjusted for currency, this was a robust increase of 10%. Volumes have grown in both the Medical Devices and Pharma Packaging sectors.

Integrated Solutions sales rose by 71%, amounting to SEK 1,186 million (692); adjusted for currency, sales increased by an exceptionally strong 66%. Very high volumes were delivered for the vaporiser heating products (VHP) product area during the quarter. Heating devices in particular enjoyed high launch volumes and inventory build-up at customers. In the second half of 2018, end-customer demand is expected to account for the majority of volumes at a persistently high level, although lower than in the second quarter, which was positively affected by both launches and inventory buildup. Mobile phone volumes remained relatively weak in the quarter. The business area is set to launch production in Suzhou in the second half of the year in order to transfer parts of production from Beijing. The new establishment will broaden our geographical presence, and help the company gain greater flexibility and diversification.

Industrial Solutions sales amounted to SEK 554 million (489); adjusted for currency, sales increased by a very strong 12%. There was positive development of volumes in almost all product areas, particularly automotive and hygiene.

The Group's operating profit (EBITA) increased by a healthy 49% to SEK 266 million (178) in the second quarter.

Operating profit (EBITA) increased to SEK 73 million (64) for Medical Solutions, to SEK 140 million (73) for Integrated Solutions and to SEK 55 million (48) for Industrial Solutions.

The EBITA margin for Medical Solutions was 13.0% (12.9). For Integrated Solutions, the EBITA margin rose to a very strong 11.8% (10.5). Extremely high volumes have had a positive impact on the margin compared with the same quarter last year. The lower margin compared with the first quarter of this year is attributable to a more favourable and balanced capacity utilisation during the first quarter. The EBITA margin for Industrial Solutions was 9.9% (9.8). Overall, the Group's EBITA margin grew to a healthy 11.6% (10.6).

Operating profit (EBIT) was SEK 264 million (174).

Profit after net financial income/expense was SEK 257 million (170). Net financial income/expense included exchange rate fluctuations affecting earnings by SEK –2 million (–2) in the second quarter.

Profit after tax rose to SEK 204 million (131). Basic earnings per share were SEK 7.75 (4.98). Adjusted basic earnings per share excluding amortisation of intangible assets arising from acquisitions increased to SEK 7.83 (5.09).

Sales, operating profit (EBITA) and EBITA margin by business area

Profit Basic adjusted earnings per share

Sales Sales Op. Profit Op. Profit EBITA margin EBITA margin
SEK million Q2/2018 Q2/2017 EBITA Q2/2018 EBITA Q2/2017 Q2/2018 Q2/2017
Medical Solutions 562 498 73 64 13.0% 12.9%
Integrated Solutions 1,186 692 140 73 11.8% 10.5%
Industrial Solutions 554 489 55 48 9.9% 9.8%
Intra-Group adj., Parent Co – 4 – 2 – 7
Group total 2,302 1,675 266 178 11.6% 10.6%

Operating profit (EBITA): Earnings before financial income and expense, taxes and amortisation of intangible assets arising from acquisitions.

First six months 2018

Sales and earnings

Consolidated sales rose by 43% to SEK 4,341 million (3,045) for the first six months of 2018. Adjusted for currency, sales increased by a very strong 43%.

Sales for Medical Solutions rose by 11% to SEK 1,094 million (985), for Integrated Solutions by 95% to SEK 2,125 million (1,091) and for Industrial Solutions by 15% to SEK 1,122 million (977).

The Group's operating profit (EBITA) increased sharply to SEK 530 million (324). Excluding non-recurring items, profit amounted to SEK 510 million (324). During the first quarter, a distribution from the previous bankruptcy of a customer in 2006 was recognised, boosting earnings by SEK 20 million (0) in other operating income. This non-recurring item has been recognised at Group level and has consequently not affected the profit of the business areas. The EBITA margin was 12.2% (10.6) Excluding nonrecurring items, the margin rose to a strong 11.7% (10.6).

Operating profit (EBIT) was SEK 525 million (316); excluding nonrecurring items, profit increased to SEK 505 million (316).

Profit after net financial income/expense was SEK 513 million (308). Profit after tax rose to SEK 410 million (239). Basic earnings per share increased to SEK 15.59 (9.09). Excluding non-recurring items, basic earnings per share amounted to SEK 14.67 (9.09). Adjusted basic earnings per share excluding amortisation of intangible assets arising from acquisitions were SEK 15.74 (9.31). The effective tax rate was 20.1% (22.4). Excluding nonrecurring items comprising the bankruptcy payment, and adjustment to a lower tax rate in Sweden, the tax rate was 21.7% (22.4).

The return on capital employed was 32.0% for the last twelve months (26.6% for the 2017 calendar year). Return on equity was 34.9% for the last 12 months (29.4% for the 2017 calendar year).

Medical Solutions

Sales and profit Q1-Q2 (SEK million) 2018 2017
Sales 1,094 985
Operating profit (EBITA) 142 129
EBITA margin (%) 13.0 13.1
Operating profit (EBIT) 139 123

Medical Solutions sales rose to SEK 1,094 million (985); adjusted for currency, sales grew by a strong 10%. Volumes increased in both the Medical Devices and Pharma Packaging sectors, but especially in Medical Devices in which the ramp-up of new customer projects made a positive contribution. Nolato's market continues to be dominated by high activity.

Operating profit (EBITA) rose to SEK 142 million (129) and the EBITA margin was 13.0% (13.1).

Strong growth has meant that, as per previously communicated decisions, Nolato is expanding production capacity in Hungary, Sweden and Switzerland. This work is proceeding according to plan and is estimated to be complete around year-end.

2017 2017 2017 2018 2018 Q2 Q3 Q4 Q1 Q2

Sales and profit Q1-Q2 (SEK million) 2018 2017
Sales 2,125 1,091
Operating profit (EBITA) 260 111
EBITA margin (%) 12.2 10.2
Operating profit (EBIT) 260 111

Integrated Solutions sales rose by 95% to SEK 2,125 million (1,091); adjusted for currency, sales increased by an exceptionally strong 99%. Very high volumes continued to be delivered for the vaporiser heating products (VHP) product area. Heating devices in particular enjoyed high launch volumes and inventory build-up at customers.

In the second half of 2018, end-customer demand is expected to account for the majority of volumes at a persistently high level, although lower than in the second quarter, which was positively affected by both launches and inventory build-up. Mobile phone volumes remained relatively weak.

Operating profit (EBITA) rose sharply to SEK 260 million (111). The EBITA margin was 12.2% (10.2).

The business area is set to launch production in Suzhou in the second half of the year in order to transfer parts of production from Beijing. The new establishment will broaden our geographical presence, and help the company gain greater flexibility and diversification.

Industrial Solutions

Sales and profit Q1-Q2 (SEK million) 2018 2017 600
Sales 1,122 977 500
400
Operating profit (EBITA) 112 96 SEK million
300
EBITA margin (%) 10.0 9.8 200
100
Operating profit (EBIT) 110 94

Industrial Solutions sales amounted to SEK 1,122 million (977); adjusted for currency, sales grew by a strong 14%. There was positive development of volumes in almost all product areas, particularly automotive and hygiene. Advanced market positions and a sustained high level of invoicing for development work and production equipment contributed to the robust growth.

Operating profit (EBITA) rose to SEK 112 million (96), with an EBITA margin of 10.0% (9.8).

Cash flow after investments in the second quarter increased to SEK 352 million (28). The sharp increase in profit has made a positive contribution. The change in working capital was very positive in the quarter despite the high growth, as a result of continued use of supplier finance programmes by the Group's customers.

Net investments affecting cash flow rose to SEK 120 million (75). Ongoing expansion of production facilities and investments in capacity in response to strong growth are resulting in increased investment.

Dividends totalling SEK 329 million (276) were paid to shareholders in the second quarter.

Cash flow after investments for the first six months also grew, to SEK 539 million (31), through increased profit and improved working capital.

Excluding non-recurring items, cash flow amounted to SEK 510 million (31). Accumulated, investments affecting cash flow totalled SEK 229 million (139).

Cash conversion for the last twelve months was 104% (66% for the 2017 calendar year).

Excluding acquisitions and disposals

Financial position

Interest-bearing assets increased to SEK 891 million (380), while interestbearing liabilities and provisions declined to SEK 829 million (1,019). Net financial assets consequently totalled SEK 62 million (net financial liability of SEK –639 million). The strong cash flow of the last 12 months has eliminated the previous net debt. Shareholders' equity rose to SEK 2,301 million (1,815). The equity/assets ratio was 43% (40).

Net financial assets (+) liabilities (-) & assets/equity ratio

Consolidated performance analysis

Q2 Q2 Q1 - Q2 Q1 - Q2 Rolling Full year
SEK million Note 2018 2017 2018 2017 12 months 2017
Net sales 1 2,302 1,675 4,341 3,045 8,016 6,720
Gross profit excl. depreciation/amortisation 395 310 792 590 1,493 1,291
As a percentage of net sales 17.2 18.5 18.2 19.4 18.6 19.2
Costs – 70 – 78 – 145 – 159 – 297 – 311
As a percentage of net sales 3.0 4.7 3.3 5.2 3.7 4.6
Operating profit (EBITDA) 325 232 647 431 1,196 980
As a percentage of net sales 14.1 13.9 14.9 14.2 14.9 14.6
Depreciation and amortisation – 59 – 54 – 117 – 107 – 227 – 217
Operating profit (EBITA) 266 178 530 324 969 763
As a percentage of net sales 11.6 10.6 12.2 10.6 12.1 11.4
Amortisation of intangible assets arising from acquisitions – 2 – 4 – 5 – 8 – 11 – 14
Operating profit (EBIT) 2 264 174 525 316 958 749
Financial income and expense 2 – 7 – 4 – 12 – 8 – 22 – 18
Profit after financial income and expense 2 257 170 513 308 936 731
Tax – 53 – 39 – 103 – 69 – 193 – 159
As a percentage of profit after financial income and exp. 20.6 22.9 20.1 22.4 20.6 21.8
Profit after tax 204 131 410 239 743 572

Financial position

SEK million 30/06/2018 30/06/2017 31/12/2017
Interest-bearing liabilities, credit institutions – 638 – 833 – 638
Interest-bearing pension liabilities – 191 – 186 – 184
Total borrowings – 829 – 1,019 – 822
Cash and bank 891 380 669
Net financial assets (+) / liabilities (–) 62 – 639 – 153
Working capital 101 535 390
As a percentage of sales (avg.) (%) 4.0 7.3 5.3
Capital employed 3,131 2,836 2,980
Return on capital employed (avg.) (%) 32.0 22.3 26.6
Shareholders' equity 2,301 1,815 2,159
Return on shareholders' equity (avg.) (%) 34.9 22.9 29.4

Personnel Contact:

The average number of employees during the period was 6,612 (6,930). The decrease in the number of employees is especially attributable to Integrated Solutions in China.

Significant risks and uncertainty factors

The business risks and risk management of the Group and the Parent Company, along with the management of financial risks, are described in the 2017 Annual Report on pages 52 – 53, and in Note 28 on pages 75 – 77.

No significant events have occurred during the period that would significantly affect or change these descriptions of the Group's and the Parent Company's risks or the management thereof.

Seasonal effects

Nolato does not experience any significant seasonal variations. However, in the third quarter sales within Industrial Solutions, and to a certain degree Medical Solutions, can be negatively affected by the fact that the holiday period falls in this quarter both for Nolato and its customers.

Events after the balance sheet date

On 5 July, the subsidiary Nolato Hertila AB was sold to Essentra International AB, which is part of Essentra Plc. Nolato Hertila is focused on the production and sale of standard products that provide protection during painting, assembly and transportation, and it was the only company of this kind in the Group. The company has 25 employees and annual sales of around SEK 40 million, with a marginal positive impact on earnings per share.

The purchase price totalled SEK 58 million. The sale will be recognised in the third quarter and is expected to result in a minor capital loss for the Group.

No other significant events have occurred since the end of the period.

Ownership and legal structure

Nolato AB (publ), Swedish corporate identity number 556080-4592, is the Parent Company of the Nolato Group.

Nolato's Class B shares are listed on the Nasdaq Stockholm exchange in the Mid Cap segment, where they are included in the Industrials sector.

There were 14,033 shareholders at 30 June. The largest shareholders are the Jorlén family with 10%, the Boström family with 9%, the Hamrin family with 8%, Lannebo Funds and SSB Client Omnibus with 5% each and Didner & Gerge Funds with 3%, of the capital.

The Parent Company

Sales in the Parent Company, which is not an operating company, amounted to SEK 31 million (27). Profit after financial income and expense amounted to SEK 101 million (56). Contingent liabilities amounted to SEK 106 million (138).

  • Christer Wahlquist, President and CEO, tel. +46705 804848
  • Per-Ola Holmström, CFO, tel. +46705 763340.

Telephone conference July 19th: Nolato invites to a telephone conference on July 19th at 15:30 CET. CEO Christer Wahlquist and CFO Per-Ola Holmström will comment the interim report. The telephone number for participation is +46 8 22 90 90 and the code is 963459.

This information is information that Nolato AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 14:30 CET on 19 July 2018.

Accounting and valuation principles

Nolato's consolidated accounts have been prepared in accordance with International Financial Reporting Standards (IFRS), as adopted by the EU.

The consolidated year-end report has been prepared in accordance with IAS 34 (Interim Financial Reporting) and the applicable provisions of the Swedish Annual Accounts Act. The Swedish Securities Market Act has been applied in relation to publication of this interim report.

The consolidated accounts have been prepared in accordance with the same principles as those applied in the most recent Annual Report, which are described in the 2017 Annual Report .

The new or revised IFRS standards or IFRIC interpretations, which came into effect on 1 January 2018, have not had any material effect on the consolidated income statement or balance sheet.

The interim report for the Parent Company was prepared in accordance with Chapter 9 of the Swedish Annual Accounts Act.

IFRS 16 Leases

IFRS 16 Leases replaces IAS 17 as of 1 January 2019. The standard removes the requirement in IAS 17 for the lessee to classify leases as either operating or finance leases, and instead introduces a collective model for all leases. In this model the lessee must recognise (a) assets and liabilities for all leases with a lease term of more than 12 months, with the exception of assets with a low value; and (b) depreciation of leased assets separately from debt interest on leases in the income statement.

Details will be provided in the next year-end report about how IFRS 16 Leases will affect consolidated financial statements.

Financial information schedule

Nine-month interim report 2018: 24 October 2018

The Board of Directors and the President give their assurance that this interim report provides a true and fair view of the operations, financial position and earnings of the company and the Group, and describe the significant risks and uncertainty factors faced by the company and the companies included in the Group.

Torekov 19 July 2018

Fredrik Arp Chairman of the Board

Board member Board member Board member

Dag Andersson Sven Boström-Svensson Lovisa Hamrin

Åsa Hedin Henrik Jorlén Lars-Åke Rydh

Board member Board member Board member

Jenny Sjödahl Björn Jacobsson Håkan Svensson Board member Board member Board member

Employee representative Employee representative

Christer Wahlquist President and CEO

Review report

Nolato AB, corporate identity number 556080-4592

Introduction

We have reviewed the condensed interim report for Nolato AB as at June 30, 2018 and for the six months period then ended. The Board of Directors and the Managing Director are responsible for the preparation and presentation of this interim report in accordance with IAS 34 and the Swedish Annual Accounts Act. Our responsibility is to express a conclusion on this interim report based on our review.

Scope of review

We conducted our review in accordance with the International Standard on Review Engagements, ISRE 2410 Review of Interim Financial Statements Performed by the Independent Auditor of the Entity. A review consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing and other generally accepted auditing standards in Sweden.

The procedures performed in a review do not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the interim report is not prepared, in all material respects, in accordance with IAS 34 and the Swedish Annual Accounts Act regarding the Group, and in accordance with the Swedish Annual Accounts Act regarding the Parent Company.

Torekov 19 July 2018

Ernst & Young AB Joakim Falck Authorised public accountant

The company in brief

Nolato's business

Nolato develops and manufactures products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, consumer electronics, telecom, automotive and other selected industrial sectors.

Operations encompass everything from individual components, which the customer assembles in its own product, to complete products that are ready for delivery to a customer's client.

Nolato also develops and manufactures its own products, such as pharmaceutical packaging.

Nolato's business model

Nolato's business model is based on close, long-term, innovative collaboration with our customers. By being part of their process at an early stage and providing support during both the development and production phases, Nolato helps its customers create a product that is as competitive as possible.

Nolato creates added value for its customers and owners through progressive, leading technology, extensive expertise in development and design, advanced project management and highly efficient production.

Nolato's strategies

  • Early involvement in customers' development processes
  • Close and long-term collaboration/partnerships with our customers
  • Innovative, integrated and high-tech solutions
  • High productivity/Lean manufacturing
  • Advancing up the value chain/Greater added value
  • Global presence
  • Responsible business practice

Consolidated income statement (summary)

Q2 Q2 Q1 - Q2 Q1 - Q2 Rolling Full year
SEK million Note 2018 2017 2018 2017 12 months 2017
Net sales 1 2,302 1,675 4,341 3,045 8,016 6,720
Cost of goods sold – 1,966 – 1,418 – 3,664 – 2,559 – 6,747 – 5,642
Gross profit 336 257 677 486 1,269 1,078
Other operating income 2 5 22 5 29 12
Selling expenses – 30 – 30 – 61 – 61 – 116 – 116
Administrative expenses – 59 – 53 – 109 – 104 – 210 – 205
Other operating expenses 15 – 5 – 4 – 10 – 14 – 20
– 72 – 83 – 152 – 170 – 311 – 329
Operating profit 2 264 174 525 316 958 749
Financial income and expense 2 – 7 – 4 – 12 – 8 – 22 – 18
Profit after financial income and expense 2 257 170 513 308 936 731
Tax – 53 – 39 – 103 – 69 – 193 – 159
Profit after tax 204 131 410 239 743 572
All earnings are attrib. to the Parent Co.'s shareholders
Depreciation/amortisation 61 58 122 115 238 231
Basic earnings per share, SEK* 3 7.75 4.98 15.59 9.09 28.23 21.74
Diluted earnings per share, SEK* 3 7.70 4.98 15.52 9.09 28.16 21.74
Number of shares at the end of the period, before dilution* 26,307,408 26,307,408 26,307,408 26,307,408 26,307,408 26,307,408
Number of shares at the end of the period, after dilution* 26,480,767 26,307,999 26,480,767 26,307,999 26,480,767 26,342,651
Average number of shares, before dilution* 26,307,408 26,307,408 26,307,408 26,307,408 26,307,408 26,307,408
Average number of shares, after dilution* 26,478,393 26,307,999 26,424,425 26,307,605 26,367,472 26,315,844

* At the end of the period the Group had two share warrant programmes, Series 1 and Series 2. Series 1 has redemptions from 01/05/2019 to 15/12/2019 and Series 2 from 01/05/2020 to 15/12/2020. The subscription price is SEK 296.30 for Series 1 and SEK 485.10 for Series 2. The programmes have been taken into account in calculating the number of shares after dilution. Upon full subscription, the programmes provide a maximum of 436,700 new class B shares.

Consolidated comprehensive income

Q2 Q2 Q1 - Q2 Q1 - Q2 Rolling Full year
SEK million 2018 2017 2018 2017 12 months 2017
Profit after tax 204 131 410 239 743 572
Other comprehensive income
Items that cannot be transferred to profit for the period
Revaluations of defined benefit pension plans 16 16 16
Tax attributable to items that cannot be transferred to
profit for the period – 3 – 3 1 – 2
13 13 1 14
Items that have been converted or can be converted into
profit for the period
Translation differences for the period on transl. of foreign oper. 17 – 9 64 – 14 72 – 6
– 4 2 – 4 4 – 5 3
1 – 1 1 – 1 1 – 1
14 – 8 61 – 11 68 – 4
Other comprehensive income, net of tax 14 5 61 2 69 10
Total comp. income for the period attributable to the
Parent Co.'s shareholders
218 136 471 241 812 582
Changes in the fair value of cash flow hedges for the period
Tax attr. to changes in the fair value of cash flow hedges

* Financial instruments are measured at fair value in the statement of financial position, pursuant to measurement hierarchy Level 2.

Consolidated balance sheet (summary)

SEK million 30/06/2018 30/06/2017 31/12/2017
Assets
Non-current assets
Intangible non-current assets 845 835 813
Property, plant and equipment 1,410 1,219 1,243
Non-current financial assets 2 2 2
Other non-current receivables 1 1 1
Deferred tax assets 56 43 52
Total fixed assets 2,314 2,100 2,111
Current assets
Inventories 769 539 530
Accounts receivable 974 1,186 1,128
Other current assets* 2) 433 282 314
Cash and bank 891 380 669
Total current assets 3,067 2,387 2,641
Total assets 5,381 4,487 4,752
Shareholders' equity and liabilities
Shareholders' equity 2,301 1,815 2,159
1)
Long-term liabilities and provisions
802 785 757
Deferred tax liabilities1) 85 94 103
Current liabilities and provisions* 1) 3) 2,193 1,793 1,733
Total liabilities and provisions 3,080 2,672 2,593
Total shareholders' equity and liabilities 5,381 4,487 4,752
1) Interest-bearing/non-interest-bearing liabilities and provisions:
Interest-bearing liabilities and provisions 829 1,019 822
Non-interest-bearing liabilities and provisions 2,251 1,653 1,771
Total liabilities and provisions 3,080 2,672 2,593
* Financial instruments are measured at fair value in the statement of financial position, pursuant to
measurement hierarchy Level 2.
2) Derivative assets are included in other current assets at 26 8
3) Derivative liabilities are included in current liabilities and provisions at 22

Changes in consolidated shareholders' equity (summary)

Q1 - Q2 Q1 - Q2 Full year
2018 2017 2017
2,159 1,850 1,850
471 241 582
– 329 – 276 – 276
3
2,301 1,815 2,159

In 2018, a dividend totalling SEK 329 million was paid to the Parent Company's shareholders, corresponding to a dividend of SEK 12.50 per share. At the end of the period the Group had two share warrant programmes, Series 1 and Series 2. Series 1 has redemptions from 01/05/2019 to 15/12/2019 and Series 2 from 01/05/2020 to 15/12/2020. The subscription price is SEK 296.30 for Series 1 and SEK 485.10 for Series 2. The programmes have been taken into account in calculating the number of shares after dilution. Upon full subscription, the programmes provide a maximum of 436,700 new class B shares.

Consolidated cash flow statement (summary)

Q2 Q2 Q1 - Q2 Q1 - Q2 Rolling Full year
SEK million 2018 2017 2018 2017 12 months 2017
Cash flow from op. activities bef. changes in work. cap. 215 196 502 364 1,037 899
Changes in working capital 257 – 93 266 – 194 334 – 126
Cash flow from operating activities 472 103 768 170 1,371 773
Cash flow from investment activities – 120 – 75 – 229 – 139 – 367 – 277
Cash flow before financing activities 352 28 539 31 1,004 496
Cash flow from financing activities – 295 48 – 368 – 52 – 538 – 222
Cash flow for the period 57 76 171 – 21 466 274
Cash and cash equivalents at the beginning of the period 817 311 669 411 411
Exchange rate difference in liquid assets 17 – 7 51 – 10 – 16
Cash and cash equivalents at the end of the period 891 380 891 380 669

Note 1 Revenue from contracts with customers

Q1 - Q2 - 2018 Q1 - Q2 - 2017 Full year - 2017
Medical Integr. Indust. Medical Integr. Indust. Medical Integr. Indust.
SEK million Sum Sol. Sol. Sol. Sum Sol. Sol. Sol. Sum Sol. Sol. Sol.
Sweden 650 75 34 541 630 86 84 460 1,235 167 122 946
Other Europe 1,291 722 100 469 1,166 651 81 434 2,297 1,288 164 845
North America etc. 346 255 17 74 310 216 40 54 613 429 66 118
Asia 2,054 42 1,974 38 947 32 886 29 2,588 71 2,458 59
Elimination internal sales – 8 – 13
Tot. revenues fr. customer contracts 4,341 1,094 2,125 1,122 3,045 985 1,091 977 6,720 1,955 2,810 1,968

The above table essentially covers products transferred at a specific date.

For the first six months of the year, the Group recognised additional impairment of trade receivables and contract assets of SEK 11 million, recognised in cost of goods sold (last year additional impairment of SEK 1 million, recognised in net sales).

Note 2 Reconciliation of consolidated income before tax

2017
123 263 247
111 481 332
94 207 191
– 12 7 – 21
316 958 749
– 8 – 22 – 18
308 936 731
139
260
110
16
525
– 12
513
2018
2017
12 months

* Including non-recurring items of SEK 20 million in Q1 2018 that had a positive impact on earnings.

Note 3 Earnings per share (IFRS measures)

Q2 Q2 Q1 - Q2 Q1 - Q2 Rolling Full year
SEK million 2018 2017 2018 2017 12 months 2017
Profit after tax 204 131 410 239 743 572
Average number of shares, before dilution 26,307,408 26,307,408 26,307,408 26,307,408 26,307,408 26,307,408
Basic earnings per share (SEK) 7.75 4.98 15.59 9.09 28.23 21.74
Non-recurring items – 3 – 24 – 24
Profit after tax excl. non-recurring items 201 131 386 239 719 572
Basic earnings per share excl. non-recurring items (SEK) 7.64 4.98 14.67 9.09 27.32 21.74
Dilutive shares from Series 1 incentive programme with
exercise price SEK 296.30 per share; total 240,500 warrants 126,734 591 92,503 197 35,550 8,436
Dilutive shares from Series 2 incentive programme with
exercise price SEK 485.10 per share; total 196,200 warrants 44,251 24,514 24,514
Average number of shares, after dilution 26,478,393 26,307,999 26,424,425 26,307,605 26,367,472 26,315,844
Diluted earnings per share (SEK) 7.70 4.98 15.52 9.09 28.16 21.74
Diluted earnings per share excl. non-recurring items (SEK) 7.59 4.98 14.61 9.09 27.25 21.74
Number of shares at the end of the period, before dilution 26,307,408 26,307,408 26,307,408 26,307,408 26,307,408 26,307,408
Number of shares at the end of the period, after dilution 26,480,767 26,307,999 26,480,767 26,307,999 26,480,767 26,342,651

At the end of the period the Group had two share warrant programmes, Series 1 and Series 2. Series 1 has redemptions from 01/05/2019 to 15/12/2019 and Series 2 from 01/05/2020 to 15/12/2020. The subscription price is SEK 296.30 for Series 1 and SEK 485.10 for Series 2. The programmes have been taken into account in calculating the number of shares after dilution. Upon full subscription, the programmes provide a maximum of 436,700 new class B shares.

Adjusted earnings per share (alternative performance measures)

Q2 Q2 Q1 - Q2 Q1 - Q2 Rolling Full year
SEK million 2018 2017 2018 2017 12 months 2017
Profit after tax 204 131 410 239 743 572
Adjusted earnings:
Amortisation of intangible assets arising from acquisitions 2 4 5 8 11 14
Tax on amortisation – 1 – 1 – 2 – 2 – 3
Adjusted earnings 206 134 414 245 752 583
Average number of shares, before dilution 26,307,408 26,307,408 26,307,408 26,307,408 26,307,408 26,307,408
Basic adjusted earnings per share (SEK) 7.83 5.09 15.74 9.31 28.58 22.16
Non-recurring items – 3 – 24 – 24
Adjusted earnings after tax, excl. non-recurring items 203 134 390 245 728 583
Basic adjusted earnings per share excl. non-rec. items (SEK) 7.72 5.09 14.82 9.31 27.67 22.16
Average number of shares, after dilution 26,478,393 26,307,999 26,424,425 26,307,605 26,367,472 26,315,844
Diluted adjusted earnings per share (SEK) 7.78 5.09 15.67 9.31 28.50 22.15
Diluted adjusted earnings per share excl. non-rec. items (SEK) 7.67 5.09 14.76 9.31 27.60 22.15

Five-year overview

IFRS measures 2017 2016 2015 2014 2013
Operating profit (EBIT) (SEK million) 749 443 556 454 411
Earnings per share, before and after dilution (SEK) 21.74 12.77 15.97 13.84 11.94
Alternative performance measures
Net sales (SEK million) 6,720 4,447 4,726 4,234 4,522
Operating profit (EBITA) (SEK million) 763 457 570 470 427
EBITA margin (%) 11.4 10.3 12.1 11.1 9.4
Profit after financial income and expense (SEK million) 731 438 555 462 403
Profit after tax (SEK million) 572 336 420 364 314
Cash flow after investments, excl. acq. and disposals (SEK million) 496 245 288 127 362
Cash conversion (%) 66 55 52 28 82
Return on capital employed (%) 26.6 20.6 29.6 28.4 26.7
Return on shareholders' equity (%) 29.4 19.0 25.3 25.0 24.9
Net financial liabilities (–) assets (+) (SEK million) – 153 – 408 122 59 122
Equity/assets ratio (%) 45 47 54 54 52
Basic adjusted earnings per share (SEK) 22.16 13.19 16.35 14.29 12.39
Dividend per share (SEK) 12,50 10.50 10.00 8.50 8.00
Average number of employees 7,249 6,418 7,759 8,020 9,357

Including any non-recurring items.

Quarterly data (summary)

IFRS measures Note Q1* Q2 Q3 Q4 Full year
Operating profit (EBIT) (SEK million) 2 2018 261 264
2 2017 142 174 206 227 749
2016 110 106 101 126 443
Basic earnings per share (SEK) 3 2018 7.83 7.75
3 2017 4.11 4.98 5.82 6.84 21.74
2016 3.16 3.00 3.00 3.61 12.77
Diluted earnings per share (SEK) 3 2018 7.80 7.70
3 2017 4.11 4.98 5.82 6.84 21.74
2016 3.16 3.00 3.00 3.61 12.77
Alternative performance measures
Net sales (SEK million) 1 2018 2,039 2,302
1 2017 1,370 1,675 1,749 1,926 6,720
2016 1,022 1,037 1,036 1,352 4,447
Operating profit (EBITDA) (SEK million) 2018 322 325
2017 199 232 263 286 980
2016 155 152 149 180 636
Operating profit (EBITA) (SEK million) 2018 264 266
2017 146 178 209 230 763
2016 113 110 104 130 457
EBITA margin (%) 2018 12.9 11.6
2017 10.7 10.6 11.9 11.9 11.4
2016 11.1 10.6 10.0 9.6 10.3
Profit after financial income and expense (SEK million) 2 2018 256 257
2 2017 138 170 198 225 731
2016 109 103 101 125 438
Profit after tax (SEK million) 2018 206 204
2017 108 131 153 180 572
2016 83 79 79 95 336
Cash flow from operating activities (SEK million) 2018 296 472
2017 67 103 381 222 773
2016 93 113 70 190 466
Cash flow from operations per share before dilution (SEK) 2018 11.25 17.94
2017 2.55 3.92 14.48 8.44 29.38
2016 3.54 4.30 2.66 7.22 17.71
Cash flow after investments, excl. acq. and disp. (SEK million) 2018 187 352
2017 3 28 308 157 496
2016 30 61 19 135 245
Cash fl. aft. inv., excl. acq. and disp. per sh. bef. dilut. (SEK) 2018 7.11 13.38
2017 0.11 1.06 11.71 5.97 18.85
2016 1.14 2.32 0.72 5.13 9.31
Basic adjusted earnings per share (SEK) 3 2018 7.91 7.83
3 2017 4.22 5.09 5.93 6.92 22.16
2016 3.23 3.12 3.12 3.72 13.19
Shareholders' equity per share, before dilution (SEK) 2018 92 87
2017 74 69 74 82 82
2016 70 63 66 70 70
Return on total capital (%) 2018 18.8 19.6
2017 14.0 14.8 16.1 17.1 17.1
2016 17.8 16.0 14.7 13.7 13.7
Return on capital employed (%) 2018 29.8 32.0
2017 20.8 22.3 24.7 26.6 26.6
2016 27.2 24.8 22.4 20.6 20.6
Return on operating capital (%) 2018 36.8 41.1
2017 24.3 25.7 29.1 32.1 32.1
2016 34.2 28.9 26.1 24.4 24.4
Return on shareholders' equity (%) 2018 32.6 34.9
2017 20.0 22.9 26.2 29.4 29.4
2016 23.2 22.5 19.7 19.0 19.0
Closing share price Nolato B (Nasdaq Stockholm) 2018 609.00 723.00
2017 267.00 316.50 393.00 539.00 539.00
2016 227.50 221.50 263.00 263.00 263.00

* Including non-recurring items of SEK 20 million in Q1 2018 that had a positive impact on earnings.

Quarterly data business areas

Alternative performance measures

Net sales (SEK million) Note Q1 Q2 Q3 Q4 Full year
Medical Solutions 1 2018 532 562
1 2017 487 498 459 511 1,955
2016 390 397 395 463 1,645
Integrated Solutions 1 2018 939 1,186
1 2017 399 692 819 900 2,810
2016 300 311 343 448 1,402
Industrial Solutions 1 2018 568 554
1 2017 488 489 473 518 1,968
2016 334 331 301 443 1,409
Group adjustments, Parent Company 1 2018
1 2017 – 4 – 4 – 2 – 3 – 13
2016 – 2 – 2 – 3 – 2 – 9
Group total 1 2018 2,039 2,302
1 2017 1,370 1,675 1,749 1,926 6,720
2016 1,022 1,037 1,036 1,352 4,447
Operating profit (EBITA) (SEK million) Q1 Q2 Q3 Q4 Full year
Medical Solutions 2018 69 73
EBITA margin (%) 13.0 13.0
2017 65 64 60 68 257
EBITA margin (%) 13.3 12.9 13.1 13.3 13.1
2016 52 53 52 59 216
EBITA margin (%) 13.3 13.4 13.2 12.7 13.1
Integrated Solutions 2018 120 140
EBITA margin (%) 12.8 11.8
2017 38 73 105 116 332
EBITA margin (%) 9.5 10.5 12.8 12.9 11.8
2016 33 28 29 41 131
EBITA margin (%) 11.0 9.0 8.5 9.2 9.3
Industrial Solutions 2018 57 55
EBITA margin (%) 10.0 9.9
2017 48 48 47 52 195
EBITA margin (%) 9.8 9.8 9.9 10.0 9.9
2016 34 34 30 36 134
EBITA margin (%) 10.2 10.3 10.0 8.1 9.5
Group adjustments, Parent Company* 2018 18 – 2
2017 – 5 – 7 – 3 – 6 – 21
2016 – 6 – 5 – 7 – 6 – 24
Group total 2018 264 266
EBITA margin (%) 12.9 11.6
2017 146 178 209 230 763
EBITA margin (%) 10.7 10.6 11.9 11.9 11.4
2016 113 110 104 130 457
EBITA margin (%) 11.1 10.6 10.0 9.6 10.3
* Including non-recurring items of SEK 20 million in Q1 2018 that had a positive impact on earnings.

* Including non-recurring items of SEK 20 million in Q1 2018 that had a positive impact on earnings.

Depreciation/amortisation
(SEK million)
Q1 Q2 Q3 Q4 Full year
Medical Solutions 2018 28 28
2017 27 27 27 27 108
2016 22 22 23 25 92
Integrated Solutions 2018 8 8
2017 9 8 8 8 33
2016 9 9 9 9 36
Industrial Solutions 2018 25 25
2017 21 22 23 24 90
2016 14 15 16 20 65
Group total 2018 61 61
2017 57 57 58 59 231
2016 45 46 48 54 193

Group financial highlights

Q2 Q2 Q1 - Q2 Q1 - Q2 Rolling Full year
IFRS measures Note 2018 2017 2018* 2017 12 months* 2017
Basic earnings per share (SEK) 3 7.75 4.98 15.59 9.09 28.23 21.74
Diluted earnings per share (SEK) 3 7.70 4.98 15.52 9.09 28.16 21.74
Alternative performance measures
Net sales (SEK million) 1 2,302 1,675 4,341 3,045 8,016 6,720
Sales growth (%) 37 62 43 48 48 51
Percentage of sales outside Sweden (%) 86 82 85 80 84 82
Operating profit (EBITDA) (SEK million) 325 232 647 431 1,196 980
1)
Operating profit (EBITA) (SEK million)
266 178 530 324 969 763
1)
EBITA margin (%)
11.6 10.6 12.2 10.6 12.1 11.4
Profit after financial income and expense (SEK million) 2 257 170 513 308 936 731
1)
Profit margin (%)
11.2 10.1 11.8 10.1 11.7 10.9
Profit after tax (SEK million) 204 131 410 239 743 572
1)
Return on total capital (%)
19.6 14.8 19.6 14.8 19.6 17.1
1)
Return on capital employed (%)
32.0 22.3 32.0 22.3 32.0 26.6
1)
Return on operating capital (%)
41.1 25.7 41.1 25.7 41.1 32.1
1)
Return on shareholders' equity (%)
34.9 22.9 34.9 22.9 34.9 29.4
Equity/assets ratio (%) 43 40 43 40 43 45
Debt/equity (%) 36 56 36 56 36 38
Interest coverage ratio (times) 35 60 41 59 46 56
Net investm. affecting cash flow, excl. acquisitions and
disposals (SEK million) 120 75 229 139 367 277
Cash flow after investments, excl. acquisitions and
disposals (SEK million) 352 28 539 31 1,004 496
1)
Cash conversion (%)
104 66
Net financial assets (+) / liabilities (–) (SEK million) 62 – 639 62 – 639 62 – 153
Basic adjusted earnings per share (SEK) 3 7.83 5.09 15.74 9.31 28.58 22.16
Diluted adjusted earnings per share (SEK) 3 7.78 5.09 15.67 9.31 28.50 22.15
Cash flow from operations per share, before dilution (SEK) 17.94 3.92 29.19 6.46 52.11 29.38
Cash flow from operations per share, after dilution (SEK) 17.83 3.92 29.04 6.46 52.00 29.37
Cash flow after investments per share, excl. acquisitions 13.38 1.06 20.49 1.18 38.16 18.85
and disposals, before dilution (SEK)
Cash flow after investments per share, excl. acquisitions 13.29 1.06 20.38 1.18 38.08 18.85
and disposals, after dilution (SEK)
Shareholders' equity per share, basic and diluted (SEK) 87 69 82
6,612 6,930 7,249
Average number of employees

* Including non-recurring items of SEK 20 million in Q1 2018 that had a positive impact on earnings.

1) KPIs calculated as specified on page 21.

Definitions - IFRS measures

Earnings for the period that are attributable to the parent company's owners divided by the average number of outstanding shares.

Definitions - Alternative performance measures

Nolato presents certain financial measures in this report that are not defined according to IFRS. Nolato considers that these measures provide valuable supplementary information for investors and company management, as they enable an assessment of trends and the company's performance. Since not all companies calculate financial measures in the same way, these are not always comparable to measures used by other companies. These financial measures should not therefore be regarded as substitutes for measures defined according to IFRS.

Profit after financial income and expense, plus financial expenses as a percentage of average total capital in the balance sheet.

Return on capital employed Cash conversion

Profit after financial income and expense, plus financial expenses as a percentage of average capital employed. Capital employed consists of total capital less non-interest-bearing liabilities and provisions.

Return on operating capital Net debt

Operating profit as a percentage of average operating capital. Operating capital consists of total capital less non-interest-bearing liabilities and provisions, less interest-bearing assets.

Return on shareholders' equity

Profit after tax as a percentage of average shareholders' equity.

EBITA margin

Operating profit (EBITA) as a percentage of net sales.

Average number of shares Operating profit (EBITA)

The average basic number of shares comprises the parent company's weighted average number of outstanding shares during the period. After dilution, a weighted average of the shares that may be issued under the ongoing share warrant programme is added, but only insofar as the average listed share price for the period exceeds the subscription price of the warrants.

Adjusted earnings per share

Profit after tax, excluding amortisation of intangible assets arising from acquisitions, divided by the average number of shares.

Cash flow from operating activities per share

Cash flow from operating activities, divided by the average number of shares.

Earnings per share Operating profit (EBIT)

Earnings before financial income and expense and taxes.

Return on total capital Cash flow per share, excl. acq. and disposals

Cash flow before financing activities, divided by the average number of shares.

Cash flow after investments, excl. acquisitions and disposals, divided by operating profit (EBIT). Cash flow and operating profit have been adjusted by non-recurring items, if any.

Interest coverage ratio Interest-bearing liabilities and provisions less interest-bearing assets.

Profit after financial income and expense, plus financial expenses, divided by financial expenses.

Operating profit (EBITDA)

Earnings before financial income and expense, taxes and depreciation/ amortisation.

Earnings before financial income and expense, taxes and amortisation of intangible assets arising from acquisitions.

Debt/equity ratio

Interest-bearing liabilities and provisions divided by shareholders' equity.

Equity/assets ratio

Profit margin Shareholders' equity as a percentage of total capital in the balance sheet.

Profit after financial income and expense as a percentage of net sales.

Forward-looking information

Some of the items reported relate to future events and actual outcomes may differ materially. In addition to those factors explicitly commented on, other factors may also materially affect the actual outcome, such as economic conditions, exchange rates and interest rate levels, political risks, competition and pricing, product development, commercialisation and technical difficulties, supply problems and customer credit losses.

Alternative performance measures

Q2 Q2 Q1 - Q2 Q1 - Q2 Rolling Full year
SEK million unless otherwise specified Note 2018 2017 2018 2017 12 months 2017
Operating profit (EBITDA) 325 232 647 431 1,196 980
Non-recurring items – 20 – 20
Adjusted operating profit (EBITDA) 325 232 627 431 1,176 980
Operating profit (EBIT) 2 264 174 525 316 958 749
Reversal of amortisation of intangible assets arising
in connection with acquisitions 2 4 5 8 11 14
Operating profit (EBITA) 266 178 530 324 969 763
Non-recurring items – 20 – 20
Adjusted operating profit (EBITA) 266 178 510 324 949 763
EBITA margin (%) 11.6 10.6 12.2 10.6 12.1 11.4
Adjusted EBITA margin (%) 11.6 10.6 11.7 10.6 11.8 11.4
Profit after financial income and expense 2 257 170 513 308 936 731
Non-recurring items – 20 – 20
Adjusted profit after financial income and expense 257 170 493 308 916 731
Profit margin (%) 11.2 10.1 11.8 10.1 11.7 10.9
Adjusted profit margin (%) 11.2 10.1 11.4 10.1 11.4 10.9
Profit after tax 204 131 410 239 743 572
Non-recurring items – 20 – 20
Tax on non-recurring items – 3 – 4 – 4
Adjusted profit after tax 201 131 386 239 719 572
Cash flow after investm., excl. acquisitions and disposals 1,004 496
Non-recurring items (affecting cash flow) – 29
Adjusted cash fl. after investm., excl. acq. and disposals 975 496
Operating profit (EBIT) 2 958 749
Non-recurring items – 20
Adjusted operating profit (EBIT) 938 749
Cash conversion (%) 104 66

Non-recurring items consist of a distribution from the previous bankruptcy of a customer in 2006. This boosted earnings by SEK 20 million (0) in other operating income. This non-recurring item has been recognised at Group level and has consequently not affected the profit of the business areas.

Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3 Q2
SEK million unless otherwise specified 2018 2018 2017 2017 2017 2017 2016 2016 2016
Profit after financial income and expense, rolling 12 months 936 849 731 631 534
Financial expense, rolling 12 months 21 16 13 13 9
Adjusted profit after financial income and exp., rolling 12 months 957 865 744 644 543
Total capital, accumulated for the period 5,381 5,148 4,752 4,612 4,487 3,967 3,924 3,025 2,948
Average total capital, last 5 quarters 4,876 4,593 4,348 4,003 3,670
Return on total capital (%) 19.6 18.8 17.1 16.1 14.8
Adjusted profit after financial income and exp., rolling 12 months 957 865 744 644 543
Capital employed, accumulated for the period 3,131 3,188 2,980 2,836 2,836 2,676 2,668 2,033 1,958
Average capital employed, last 5 quarters 2,994 2,903 2,799 2,610 2,434
Return on capital employed (%) 32.0 29.8 26.6 24.7 22.3
Operating profit (EBIT), rolling 12 months 958 868 749 648 543
Capital employed, accumulated for the period 3,131 3,188 2,980 2,836 2,836 2,676 2,668 2,033 1,958
Cash and bank – 891 – 817 – 669 – 561 – 380 – 311 – 411 – 240 – 250
Operating capital, accumulated for the period 2,240 2,371 2,311 2,275 2,456 2,365 2,257 1,793 1,708
Average operating capital, latest 5 quarters 2,331 2,356 2,333 2,229 2,116
Return on operating capital (%) 41.1 36.8 32.1 29.1 25.7
Profit after tax, rolling 12 months 743 670 572 487 413
Shareholders' equity, accumulated for the period 2,301 2,412 2,159 1,950 1,815 1,955 1,850 1,741 1,653
Average shareholders' equity, latest 5 quarters 2,127 2,058 1,946 1,862 1,803
Return on shareholders' equity (%) 34.9 32.6 29.4 26.2 22.9

Parent Company income statement (summary)

Q2 Q2 Q1 - Q2 Q1 - Q2 Rolling Full year
SEK million 2018 2017 2018 2017 12 months 2017
Net sales 15 13 31 27 54 50
Selling expenses – 1 – 3 – 3 – 4 – 5 – 6
Administrative expenses – 13 – 14 – 25 – 29 – 47 – 51
Other operating income 1 2 4 2 8 6
Other operating expenses – 13 – 6 – 22 – 13 – 34 – 25
Operating profit – 11 – 8 – 15 – 17 – 24 – 26
Profit from participations in Group companies 58 77 137 77 320 260
Financial income 3 5 7 10 43 46
Financial expenses – 16 – 8 – 28 – 14 – 19 – 5
Profit after financial income and expense 34 66 101 56 320 275
Appropriations 244 244
Tax – 1 – 1 – 67 – 66
Profit after tax 33 66 100 56 497 453
Depreciation/amortisation 1 1 – 1

Parent Company balance sheet (summary)

SEK million 30/06/2018 30/06/2017 31/12/2017
Assets
Intangible fixed assets 3 3 3
Property, plant and equipment 1 1 1
Financial assets 1,637 1,642 1,625
Deferred tax assets 14 14 5
Total fixed assets 1,655 1,660 1,634
Other receivables 305 277 705
Cash and bank 47 73
Total current assets 305 324 778
Total assets 1,960 1,984 2,412
Shareholders' equity and liabilities
Shareholders' equity 1,065 898 1,295
Untaxed reserves 200 163 200
Other provisions 14 13 13
Long-term liabilities 550 541 519
Current liabilities 131 369 385
Total shareholders' equity and liabilities 1,960 1,984 2,412

Transactions with related parties:

SEK million Period Services Services Interest Interest Res. from shares Rec. fr. rel. part. Liab. to rel. part.
Related party sold bought income expenses in Group comp. on bal. sh. date on bal. sh. date
Subsidiary Jan-Jun 2018 31 – 3 7 137 703 185
Subsidiary Jan-Jun 2017 27 – 2 10 77 640 182

None of the company's Board members or senior executives currently have, or have previously had, any direct or indirect involvement in any business transaction with the company which is, or was, of an unusual character in terms of its conditions. Nor has the Group issued any loans, pledged any guarantees or entered into any surety arrangements for any of the company's Board members or senior executives.

Nolato AB, SE-269 04 Torekov, Sweden • Tel. +46 431 442290 • Fax +46 431 442291 Corp. id. number 556080-4592 • E-mail [email protected] • Website www.nolato.com

Talk to a Data Expert

Have a question? We'll get back to you promptly.